Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)

NCT00367237 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Psoriatic

Interventions

DRUG: Infliximab + methotrexate (IFX + MTX)
DRUG: Methotrexate (MTX)

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]